Trends in antiseizure medication monotherapy for pediatric epilepsy in the United States

Abstract Objective National prescribing trends for antiseizure medication (ASM) in children with epilepsy over the past decade are unclear. Despite the 2021 SANAD II trials supporting lamotrigine and valproate for focal and generalized epilepsies, respectively, it is unknown if their use increased....

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Adam P. Ostendorf, Mariah Eisner, Mahmoud Abdel‐Rasoul, Stephanie M. Ahrens, Jaime D. Twanow, Howard P. Goodkin, Christopher W. Beatty
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2026-06-01
Saila:	Epilepsia Open
Gaiak:	antiseizure medication childhood epilepsy epilepsy lamotrigine levetiracetam valproic acid
Sarrera elektronikoa:	https://doi.org/10.1002/epi4.70273
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!